http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-PI0907724-B8

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8bb2c65fed767c6cdb08ca3b49dbb9f0
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5383
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-662
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-10
filingDate 2009-02-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e960afa1481fbfb728cbefe09823f2a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4878055f249c62277919175b797095f2
publicationDate 2021-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber BR-PI0907724-B8
titleOfInvention use of n4-(2,2-dimethyl-4-[(dihydrogen-phosphonoxy)methyl]-3-oxo-5-pyrido[1,4]oxazin-6-yl)-5-fluoro-n2-( 3,4,5-trimethoxyphenyl)-2,4-pyrimidinediamine or a salt thereof
abstract method for treating atherosclerosis or regressing or decreasing the formation of arterial atherosclerotic lesions. new methods and compositions for the prevention and treatment of all forms of atherosclerosis with the 2,4-pyrimidinediamine compounds are described. coating of prosthetic devices, such as probes, with the compounds of the invention for the prevention and/or treatment of restenosis is also diffused.
priorityDate 2008-02-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419512640
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID67431
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID458393636

Total number of triples: 21.